Case Study: Sumitovant Biopharma secures global cloud innovation with Palo Alto Networks

Sumitovant Biopharma securely onboards 400 users overnight with Palo Alto Networks

Sumitovant Biopharma, a biopharmaceutical company, faced the challenge of building a secure network infrastructure from the ground up to support its "cloud everything" strategy and connect a remote workforce during the pandemic. They required a solution to reduce risk across their global, multicloud environment and ensure audit-proof compliance. To meet this challenge, they partnered with Palo Alto Networks for a cloud-driven security platform.

The solution from Palo Alto Networks included the deployment of Prisma Access, Next-Generation Firewalls, GlobalProtect, and Panorama. This provided Zero Trust protection and a single management pane. The results were significant: the company immediately mitigated zero-day threats like Log4j, onboarded 400 new users securely overnight, and established one consistent global policy with zero gaps. Palo Alto Networks' platform enabled secure innovation and ensured compliance with stringent industry regulations.

Sumitovant Biopharma